Women are more likely to have pulmonary arterial hypertension, but men tend to have worse outcomes and worse treatment responses.

Heart disease has long been considered a man's disease, but the reality is far more complex. Women face unique risks, ...

Combination therapy with oral or inhaled treprostinil may benefit patients with pulmonary arterial hypertension and cardiovascular comorbidities.

A couple who had to make the difficult decision to tell doctors to halt CPR on their newborn child are opening up about ...

Eko Health, a leader in applying artificial intelligence (AI) for the early detection of heart and lung diseases, today ...

The decision to terminate the HYPERION trial reflects a loss of clinical equipoise, making it unethical to continue the placebo-controlled study.

Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...

Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...

United Therapeutics has scored a regulatory green light to start clinical trials for its genetically modified pig kidneys to ...

In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...

Severe COVID-19 infection can trigger extensive inflammation, resulting in the rapid growth of plaque in the coronary arteries and a higher risk of heart attack, stroke, and other life-threatening ...

Seropositive rheumatoid arthritis may be protective against the development of PAH, based on results of Mendelian randomization analyses.